Literature DB >> 22311230

Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage.

Michael Moussouttas1, Edwin W Lai, John Khoury, Thanh T Huynh, Keith Dombrowski, Karel Pacak.   

Abstract

BACKGROUND: Subarachnoid hemorrhage (SAH) has been associated with pronounced acute sympathetic activation. The purpose of this investigation is to identify demographic, clinical, radiological, and anatomical features of SAH that relate to sympathetic activation.
METHODS: Observational study of consecutive Grades 3-5 SAH patients requiring ventriculostomy and undergoing endovascular aneurysmal obliteration. All patients underwent cerebrospinal fluid (CSF) sampling within 48 h of SAH onset, and samples were assayed for various catecholamine compounds and metabolites. Univariate analyses were performed to identify variables associated with catecholamine levels, and to correlate linearity among catecholamine compounds and metabolites. Variables demonstrating a possible association and variables of interest were entered into linear regression models to determine predictors of catecholamine elevations.
RESULTS: Of the 102 patients, mean age was 58 years and 74% were female; 42% were Hunt-Hess (H/H) grade 4/5, 61% had a computed tomography (CT) score of 3/4, 57% had anterior cerebral or communicating artery (ACA/ACom) aneursysms, and 23% had aneurysms in the posterior circulation. In the univariate analysis, age, gender, H/H grade, CT score, and aneurysm location demonstrated various associations with catecholamine levels, and substantial positive correlations existed between the various catecholamine compounds and metabolites. Linear regression analyses revealed H/H grade to be an independent predictor of elevated CSF epinephrine (EPI), 3,4-dihydroxyphenylalanine (DOPA) and 3,4-dihydroxyphenyl acetic acid (DOPAC) levels, and of the norepinephrine/3,4-dihydroxyphenylglycol (NE/DHPG) ratio (p < 0.05 for all analyses). Female gender independently predicted increased dopamine (DA) and DOPAC levels (p < 0.05 for two analyses), as well as possibly DOPA levels (p < 0.1). Age, CT score and aneurysm location demonstrated only inconsistent associations and trends.
CONCLUSIONS: Central sympathetic activation relates to clinical severity and female gender. No definitive associations were found for age, hemorrhage amount, or aneurysm location.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311230     DOI: 10.1007/s12028-012-9673-5

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  32 in total

1.  Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage.

Authors:  Jonathan G Zaroff; Ludmila Pawlikowska; Jacob C Miss; Sirisha Yarlagadda; Connie Ha; Achal Achrol; Pui-Yan Kwok; Charles E McCulloch; Michael T Lawton; Nerissa Ko; Wade Smith; William L Young
Journal:  Stroke       Date:  2006-05-25       Impact factor: 7.914

2.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

3.  Accelerated norepinephrine turnover in peripheral tissues after ventromedial hypothalamic stimulation in rats.

Authors:  M Saito; Y Minokoshi; T Shimazu
Journal:  Brain Res       Date:  1989-03-06       Impact factor: 3.252

Review 4.  Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage.

Authors:  Nicolas Bruder; Alejandro Rabinstein
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 5.  Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage.

Authors:  Vivien H Lee; Jae K Oh; Sharon L Mulvagh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

6.  Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms.

Authors:  David Fiorella; Felipe C Albuquerque; Patrick Han; Cameron G McDougall
Journal:  Neurosurgery       Date:  2004-01       Impact factor: 4.654

7.  Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model.

Authors:  Takashi Masuda; Kiyotaka Sato; Shin-ichiro Yamamoto; Narihisa Matsuyama; Takao Shimohama; Atsuhiko Matsunaga; Shuichi Obuchi; Yoshitaka Shiba; Shinobu Shimizu; Tohru Izumi
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

8.  Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function.

Authors:  B Shivalkar; J Van Loon; W Wieland; T B Tjandra-Maga; M Borgers; C Plets; W Flameng
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

9.  Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis.

Authors:  Marek Sykora; Jennifer Diedler; Andre Rupp; Peter Turcani; Thorsten Steiner
Journal:  Stroke       Date:  2008-12-31       Impact factor: 7.914

10.  The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.

Authors:  G Ebinger; Y Michotte; P Herregodts
Journal:  J Neurochem       Date:  1987-06       Impact factor: 5.372

View more
  11 in total

Review 1.  Nutritional and Bioenergetic Considerations in Critically Ill Patients with Acute Neurological Injury.

Authors:  Peter A Abdelmalik; Susan Dempsey; Wendy Ziai
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

2.  Contrast-induced nephropathy in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Vamsidhar Chavakula; Bradley A Gross; Kai U Frerichs; Rose Du
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

3.  Early diagnosis of paroxysmal sympathetic hyperactivity in the ICU.

Authors:  Joshua D Hughes; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

4.  Preliminary report on cardiac dysfunction after isolated traumatic brain injury.

Authors:  Sumidtra Prathep; Deepak Sharma; Matthew Hallman; Aaron Joffe; Vijay Krishnamoorthy; G Burkhard Mackensen; Monica S Vavilala
Journal:  Crit Care Med       Date:  2014-01       Impact factor: 7.598

5.  Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy.

Authors:  Michael Moussouttas; Elizabeth Mearns; Arthur Walters; Matthew DeCaro
Journal:  Cerebrovasc Dis Extra       Date:  2015-06-10

6.  Subarachnoid hemorrhage induces an early and reversible cardiac injury associated with catecholamine release: one-week follow-up study.

Authors:  Reda Salem; Fabrice Vallée; François Dépret; Jacques Callebert; Jean Pierre Saint Maurice; Philippe Marty; Joaquim Matéo; Catherine Madadaki; Emmanuel Houdart; Damien Bresson; Sebastien Froelich; Christian Stapf; Didier Payen; Alexandre Mebazaa
Journal:  Crit Care       Date:  2014-10-30       Impact factor: 9.097

7.  Myocardial function at the early phase of traumatic brain injury: a prospective controlled study.

Authors:  Adrien Cuisinier; Claire Maufrais; Jean-François Payen; Stephane Nottin; Guillaume Walther; Pierre Bouzat
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-10-28       Impact factor: 2.953

Review 8.  Antioxidant Melatonin: Potential Functions in Improving Cerebral Autoregulation After Subarachnoid Hemorrhage.

Authors:  Zhen-Ni Guo; Hang Jin; Huijie Sun; Yingkai Zhao; Jia Liu; Hongyin Ma; Xin Sun; Yi Yang
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

9.  Prolonged paroxysmal sympathetic storming associated with spontaneous subarachnoid hemorrhage.

Authors:  Yan Liu; Suneil Jolly; Krishna Pokala
Journal:  Case Rep Med       Date:  2013-02-11

10.  Impact of clipping versus coiling on postoperative hemodynamics and pulmonary edema after subarachnoid hemorrhage.

Authors:  Nobutaka Horie; Mitsutoshi Iwaasa; Eiji Isotani; Shunsuke Ishizaka; Tooru Inoue; Izumi Nagata
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.